A detailed history of Clarius Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Clarius Group, LLC holds 1,508 shares of VRTX stock, worth $680,062. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,508
Previous 1,556 3.08%
Holding current value
$680,062
Previous $729,000 3.84%
% of portfolio
0.05%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$460.0 - $505.78 $22,080 - $24,277
-48 Reduced 3.08%
1,508 $701,000
Q2 2024

Jul 11, 2024

SELL
$392.81 - $485.53 $36,924 - $45,639
-94 Reduced 5.7%
1,556 $729,000
Q1 2024

Apr 17, 2024

SELL
$407.69 - $446.08 $125,568 - $137,392
-308 Reduced 15.73%
1,650 $689,000
Q4 2023

Jan 29, 2024

SELL
$343.0 - $410.68 $43,561 - $52,156
-127 Reduced 6.09%
1,958 $796,000
Q3 2023

Oct 19, 2023

SELL
$338.18 - $362.46 $140,344 - $150,420
-415 Reduced 16.6%
2,085 $725,000
Q2 2023

Aug 09, 2023

BUY
$314.42 - $351.91 $15,092 - $16,891
48 Added 1.96%
2,500 $879,000
Q1 2023

Apr 17, 2023

SELL
$283.23 - $323.1 $31,155 - $35,541
-110 Reduced 4.29%
2,452 $772,000
Q4 2022

Jan 25, 2023

BUY
$285.76 - $321.48 $17,717 - $19,931
62 Added 2.48%
2,562 $740,000
Q3 2022

Oct 24, 2022

BUY
$273.83 - $305.53 $17,525 - $19,553
64 Added 2.63%
2,500 $724,000
Q2 2022

Aug 10, 2022

BUY
$234.96 - $292.55 $74,247 - $92,445
316 Added 14.91%
2,436 $686,000
Q4 2021

Feb 02, 2022

SELL
$177.01 - $223.45 $13,452 - $16,982
-76 Reduced 3.46%
2,120 $466,000
Q3 2021

Oct 18, 2021

BUY
$181.39 - $202.99 $15,418 - $17,254
85 Added 4.03%
2,196 $398,000
Q2 2021

Aug 06, 2021

SELL
$187.49 - $221.1 $4,312 - $5,085
-23 Reduced 1.08%
2,111 $426,000
Q1 2021

Apr 27, 2021

BUY
$207.02 - $241.31 $66,246 - $77,219
320 Added 17.64%
2,134 $459,000
Q4 2020

Jan 15, 2021

BUY
$207.01 - $276.09 $27,325 - $36,443
132 Added 7.85%
1,814 $429,000
Q3 2020

Oct 09, 2020

SELL
$255.65 - $303.1 $6,902 - $8,183
-27 Reduced 1.58%
1,682 $458,000
Q2 2020

Jul 08, 2020

BUY
$225.48 - $295.8 $34,949 - $45,849
155 Added 9.97%
1,709 $496,000
Q1 2020

Apr 24, 2020

BUY
$199.77 - $247.81 $20,576 - $25,524
103 Added 7.1%
1,554 $370,000
Q4 2019

Jan 22, 2020

BUY
$166.71 - $223.91 $7,168 - $9,628
43 Added 3.05%
1,451 $340,000
Q3 2019

Oct 23, 2019

BUY
$166.23 - $187.09 $234,051 - $263,422
1,408 New
1,408 $239,000
Q2 2019

Aug 02, 2019

SELL
$164.61 - $190.37 $189,630 - $219,306
-1,152 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $188,616 - $224,294
1,152 New
1,152 $212,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.